• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH)

ACP01169

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01169 Target NameHIBADH
Target Synonyms(HIBADH)FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range37-336aa
Mol Weight39.0 kDaProtein LengthFull Length of Mature Protein
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP31937
Background Information
  • Uniprot Id

    P31937

  • Target Species

    Human

  • Target Name

    HIBADH

  • Target Full Name

    3-hydroxyisobutyrate dehydrogenase, mitochondrial

  • Target Subcellular Location

    Mitochondrion.

  • Target Protein Families

    3-hydroxyisobutyrate dehydrogenase family

  • Target Tissue Specificity

    Detected in skin fibroblasts.

  • Target Research Area

    Others

  • Target Synonyms

    3 hydroxy 2 methylpropanoate:NAD(+) oxidoreductase; 3 hydroxyisobutyrate dehydrogenase; 3 hydroxyisobutyrate dehydrogenase mitochondrial; 3-hydroxyisobutyrate dehydrogenase; 3HIDH_HUMAN; EC 1.1.1.31; HIBADH; MGC40361; mitochondrial; NS5ATP1

  • Target Background

    This gene encodes a mitochondrial 3-hydroxyisobutyrate dehydrogenase enzyme. The encoded protein plays a critical role in the catabolism of L-valine by catalyzing the oxidation of 3-hydroxyisobutyrate to methylmalonate semialdehyde.

Inquire Recombinant Human 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification